The authors concluded that imaging with the [68Ga]Ga-HER2-Affibody tracer enables a whole-body view of tumor load and HER2 expression and can be an adjunct diagnostic to guide treatment decisions in advanced gastric cancer. The gene discussed is ERBB2; the disease is neoplasm.